Tumors at the Aortoiliac/Inferior Vena Cava Bifurcation: Preoperative, Anesthetic, and Intraoperative Considerations

2007 ◽  
Vol 73 (5) ◽  
pp. 440-446
Author(s):  
James R. Ouellette ◽  
David V. Cossman ◽  
Karen S. Sibert ◽  
Nicholas P. Mcandrew ◽  
Allan W. Silberman

Primary and recurrent retroperitoneal tumors can involve the aortoiliac vasculature. They are often considered inoperable or incurable because of the locally advanced nature of the disease or the technical aspects involved in safely resecting the lesion. Safe resection of these lesions requires experience and extensive preoperative planning for success. A retrospective database review of 76 patients with retroperitoneal tumors identified tumors involving major vascular structures in the abdomen and pelvis undergoing resection of tumor en bloc with the aortoiliac vasculature. Preoperative planning and intraoperative technical maneuvers are reviewed. Patients were followed until time of this report. Four patients with retroperitoneal tumors involving the aortoiliac vessels underwent surgery: two patients with sarcoma (one primary and one recurrent), one with metastatic renal cell carcinoma, and one with a paraganglioma. All patients had resection of the aorta and vena cava or the iliac artery and vein. Arterial reconstruction (anatomic or extra-anatomic) was performed in all cases. The patient with renal cell carcinoma also required venous reconstruction to support a renal autotransplant. Veno-venous bypass was required in one patient. Local control was achieved in 3 of 4 cases. Surgery for retroperitoneal tumors involving major vascular structures is technically feasible with appropriate planning and technique. Multiple disciplines are required, including general surgical oncology, vascular surgery, and possibly, cardiothoracic surgery.

2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Andrew T. Schlussel ◽  
Aaron B. Fowler ◽  
Herbert K. Chinn ◽  
Linda L. Wong

Renal cell carcinoma (RCC) is rare but aggressive, with greater than 20% of patients presenting with stage III or IV, disease. Surgical resection of the primary tumor regardless of stage is the treatment of choice, and en bloc resection of involved organs provides the only potential chance for cure. This case report describes a patient with metastatic right-sided RCC with invasion of the inferior vena cava and duodenum managed by en block resection and pancreaticoduodenectomy. This report will review the workup and treatment of locally advanced RCC, as well as the role of cytoreductive nephrectomy in the setting of metastatic disease.


2013 ◽  
Vol 31 (6_suppl) ◽  
pp. 409-409 ◽  
Author(s):  
Joseph C. Klink ◽  
Karin E. Westesson ◽  
Tianming Gao ◽  
Andrew J. Stephenson ◽  
Venkatesh Krishnamurthi

409 Background: Inferior vena cava (IVC) tumor thrombectomy with radical nephrectomy (RN) for renal cell carcinoma (RCC) is difficult when a large renal mass is present, but completing the RN by transecting the renal vein with tumor thrombus inside can facilitate dissection of the IVC for thrombectomy. We compared the outcomes of patients in whom the thrombus was purposely transected to those in whom the IVC thrombus was removed en bloc with the kidney. Methods: At our institution between 2000-2011, 152 patients with RCC and level II (N =53), III (N =52) or IV (N =47) IVC thrombus underwent RN and IVC thrombectomy. In 92 patients the kidney was removed prior to initiating the IVC thrombectomy. In 60 patients, the tumor thrombus and kidney were removed en bloc. Clinical information was obtained from an institutional database. Since thrombus level greatly affects surgical technique and complications, outcomes were analyzed within each level. Results: Thrombus level and clinical stage were higher in the transected group, but other baseline characteristics did not differ significantly. The primary endpoint, the overall rate of complications including intra-op and post-op events, was not statistically significantly different (all p >0.2) between the en bloc and transected groups for level 2 (8/37 vs. 6/16), level 3 (7/17 vs. 15/35), and level 4 (2/6 vs. 25/41). Operative times were similar within level 2 (300 vs. 300 minutes, p=0.2), level 3 (312 vs. 360, p=0.1), and level 4 (325 vs. 402, p=0.7). Units of blood products transfused were also similar within level 2 (3 vs 5, p=0.3), level 3 (5 vs. 9, p=0.06), and level 4 (6 vs. 14, p=0.4). Due to the low event numbers within each subgroup, multivariable analysis could not be reliably run on these outcomes. Three patients, all in the transected group, experienced intraoperative tumor thrombus embolization to the pulmonary artery requiring surgical embolectomy, but all 3 survived to discharge without any serious sequelae. Conclusions: Complications, operative time, and transfusion rates were similar between the en bloc and transected techniques when stratified by tumor thrombus level. Because of the rarity of this disease, statistical power of these comparisons is low, but our study suggests no evidence of advantage to either technique.


Cancers ◽  
2021 ◽  
Vol 13 (7) ◽  
pp. 1695
Author(s):  
Javier González ◽  
Jeffrey J. Gaynor ◽  
Gaetano Ciancio

Background: The purpose of this study is to report the outcomes of a series of patients with locally advanced renal cell carcinoma (RCC) who underwent radical nephrectomy, tumor thrombectomy, and visceral resection. Patients and methods: 18 consecutive patients who underwent surgical treatment in the period 2003-2019 were included. Neoplastic extension was found extending into the pancreas, duodenum, and liver in 9(50%), 2(11.1%), and 7(38.8%) patients, respectively. Seven patients (38.8%) presented also inferior vena cava tumor thrombus level I (n = 3), II (n = 2), or III (n = 2). The resection was tailored according to the degree of invasiveness. Demographics, clinical presentation, disease characteristics, surgical details, 30-day postoperative complications, and overall survival (OS) were analyzed. Results: Median age was 56 years (range: 40–76). Median tumor size was 14.5 cm (range, 8.8–22), and 10 cm (range: 4–15) for those cases with pancreatico-duodenal and liver involvement, respectively. Median estimated blood loss (EBL) was 475 mL (range: 100–4000) and resulted higher for those cases requiring thrombectomy (300 mL vs. 750 mL). Nine patients (50%) required transfusions with a median requirement of 4 units (range: 2–8). No perioperative deaths were registered in the first 30 days. Overall complication rate was 44.4%. Major complications were detected in 6/18 patients (33.3%). Overall median follow-up was 24 months (range: 0–108). Five-year OS (actuarial) rate was 89.9% and 75%, for 9/11 patients with pancreatico-duodenal involvement and 6/7 patients with liver invasion, respectively. Conclusion: Our series establishes the technical feasibility of this procedure with acceptable complication rates, no deaths, and potential for durable response.


2014 ◽  
Vol 13 (6) ◽  
pp. e1392
Author(s):  
W. Różański ◽  
M. Markowski ◽  
M. Wrona ◽  
P. Lipiński ◽  
M. Lipiński ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document